Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...

Suven Pharma reported a 78% YoY rise in Q3FY25 net profit to Rs 83.3 crore, with revenue growing 40% to Rs 307.2 crore, driven by its CDMO ...

Suven Pharma, backed by Advent, reported a 78% year-on-year rise in net profit to Rs 83.3 crore for Q3FY25 driven by strong demand and busi...

Shares of the Ahmedabad-based biopharma company, which listed a few weeks ago at a more than 20% premium, have notched another 9% gain sinc...

This is the third big order for Anupam in a month taking the cumulative value of contracts to around ₹2,500 crore. The total order backlog ...

Patent protection, ban on fixed dose combinations among factors helping pharma MNCs

This will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend repor...

"In spite of these ongoing challenges, several Indian pharma companies are increasing their R&D spend, targeting pipeline of specialty drug...

The growth of nutraceuticals market in India accounts for around 1.5 per cent of the global market which is currently estimated at $4,182 b...

Work on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013.

Bajaj Corp (BJCorp) has acquired the personal care brand No Marks which primarily operates in the niche category of Anti Marks.

Piramal's game plan is to add to this portfolio by buying more molecules in late stages of development in niche segments.

CRISIL has assigned CRISIL IPO Grade "4/5" to the proposed initial public offer of Glenmark Generics (GGL).

We are looking at acquisitions in the US market to make an inroad. We are also concentrating on developing the BRIC countries and building ...

Mumbai-based drug major Nicholas Piramal India (NPIL) is in talks with private equity funds for the sale of a ‘small’ stake in its research...

Pharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR - an anti h...

Ahmedabad-based Torrent Pharmaceuticals on Friday said it has launched three new speciality divisions to cater to niche therapeutic areas o...